Medicare Rx Should Offer Choice Of PBMs, Drug Plan Designs, PCMA Says
Executive Summary
A Medicare prescription drug program should allow beneficiaries to choose among competing pharmacy benefit management companies and among drug plan designs, the Pharmaceutical Care Management Association said in a June 22 letter to House committee chairmen.